10/01/2026
The Scale and the Brain MRI Scan
I sat in the MS specialist, neurologist’s office alongside my daughter Kara who lives with MS, the fluorescent lights humming like a low warning. On the screen glowed her latest brain MRI: a scatter of white spots, the lesions the doctor called “active.” He leaned forward, voice measured but heavy with urgency.
“These are signs the disease is advancing. and she is about to lose her right eye sight.
Without a disease-modifying therapy, something strong, one of the heavy hitters, we can’t predict the trajectory. Disability could accelerate. We need to act now.”
Kara nodded, as she always had.
For many, the prescriptions come for years: infusions, pills, injections, each promising to quiet the invisible storm. The language never changes—activity, progression, risk. Fear, dressed as science.
That evening I stepped onto her bathroom scale. The number stared back: the same as last month, last year. I laughed. The scale told me what I weighed right now. It said nothing about whether I would gain five pounds or lose ten by winter. Diet, movement, stress, sleep, chance—those decide the future. The number was a snapshot, not a prophecy.
And then the epiphany landed, clean and cold.
A brain MRI was the same kind of scale. It showed lesions that existed today—scars, inflammation, whatever the machine could catch. But those white spots did not map the road ahead any more than the scale predicted the next decade of her body. The disease remained elusive, slippery, full of paradoxes the textbooks still struggled to explain. Some people with heavy lesion loads walked freely for decades; others with quieter scans declined. The “clinico-radiological paradox” had a name for a reason.
I thought of the old days of multiple sclerosis diagnosis: vague symptoms, clinical judgment, sometimes autopsy confirmation only after the fact. The methods had always carried doubt. Scanners got sharper, drugs got more expensive, the language grew more confident. Yet the core uncertainty lingered. What had truly changed was the money—billions flowing through the pipeline of “heavy hitter” therapies, each new molecule accompanied by the same urgent pitch: the lesions are speaking, and they say you need the drug.
I closed the laptop. The scan was information, not fate. The scale was information, not destiny. Both measured the present. Neither owned the future. The disease was still elusive. The fear was manufactured. And the only thing that had clearly progressed was the price of the prescription.
Today, Kara is managing her MS drug free, she is symptom free, never lost her vision however that World Renowned MS prescriber also Lost her Optic Never Testing.
Is MS science still as dubious as it was in the past history of MS as bunch of “Whale Tales”?
Our story~ is also the story of many who face brain disease, MS~ Cassandra Ashby
Co founder MSforTruth.org
To add to this follow up, Kara quickly went to her eye doctor and did the same optic nerve testing and it was completely negative and showed she never has had any optic nerve issues or damages.
